Clinical Trial Update: SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma [NA]

View source ↗

Summary

Clinical trial update for SIR-Spheres in unresectable hepatocellular carcinoma; trial terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SIR-Spheres (yttrium-90 glass microspheres)

Snippet

Sponsor: Sirtex Medical | Conditions: Carcinoma, Hepatocellular, Hepatoma | NA | Status: TERMINATED | Results posted: 2020-12-10